Exagen Inc
XGN
$8.48+2.79%
End of day · as of Oct 13, 2026, 7:00 PM ET
Mkt cap
$154.12M
EV/Sales
2.18
P/E ratio
N/A
FY2025 Revenue
$66.58M
EPS (TTM)
$-0.82
Gross Margin (FY2025)
58.28%
Profit Margin (FY2025)
-29.97%
Beta
1.60
Div yield
N/A
Sector
Healthcare
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported XGN revenue for 2025-12-31 was $66.6M. Net income was -$20.0M. Revenue was up 19.7% from 2024-12-31 to 2025-12-31. XGN currently screens at market cap $154.1M.
Use this XGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full XGN income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Exagen Inc (XGN) is a diagnostics & research company in the Healthcare sector.
Latest cached Exagen Inc (XGN) revenue for Dec 31, 2025 was $66.6M. Net income was -$20.0M. Statements: https://lician.com/financials/xgn
Exagen Inc (XGN) market capitalization is $154.1M on the latest cached snapshot.
Exagen Inc (XGN) cached previous close $8.25; day range $8.18 – $8.50; volume 469,985. Session quote: https://lician.com/quote/xgn
Exagen Inc (XGN) latest cached earnings event is "XGN earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached XGN filing is 8-K · Aug 4, 2026. Filings: https://lician.com/sec/xgn